alegro health semaglutide Semaglutide: A Game-Changer In Managing
Description
Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al
21% Average weight loss at 12 months: Members combining GLP-1 medications with support from WW Med+ 1 29.1% More weight loss: Members who engaged regularly with the GLP-1 Success Program at 12 months 2 87% Blood pressure change: Members prescribed weight loss medications through WW Med+ who had high blood pressure when starting, had normal blood pressure after 12 months 3 0.75 Decrease in HbA1c at six months: Members participating in the Weight Watchers Diabetes Program 4 Our consultative approach fits your priorities Our focus is on helping you define the right weight management strategy to solve your biggest weight health challenges
Blood pressure improvements and better cholesterol profiles have been noted in some participants
2024;7(1):e2352824
However, while this medication shares the active ingredient with some popular weight loss options, it is not intended for weight loss
